Ruxolitinib for Steroid-refractory GVHD
Clinical trial NCT02997280 · COMPLETED
Trial details
- NCT number
- NCT02997280
- Sponsor
- St. Petersburg State Pavlov Medical University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2018-12-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.